French healthcare company Sanofi has agreed to buy U.S. biotech firm Inhibrx in a deal valued at up to $2.2 billion, bolstering its drug development portfolio with an experimental treatment for a rare genetic disease...
Walgreens to explore sale of Shields Health for over $4 bln – Bloomberg News
Walgreens Boots Alliance is exploring a sale of specialty pharmacy company Shields Health Solutions, Bloomberg News reported on Tuesday, citing people familiar with the matter. The sale could be valued at more than $4...
Sandoz to buy eye drug Cimerli in $170 million deal
Sandoz announced a deal to buy Cimerli, a biosimilar drug to treat vision impairment and loss, from Coherus BioSciences Inc. for $170 million. The drug is interchangeable with Lucentis, a product marketed by...
GSK to sell 3.2% stake in spin-off Haleon in its third stake sale in under a year
GSK, opens new tab will sell a 3.2% stake, or about 300 million shares, in its spun-off consumer healthcare business Haleon, opens new tab, the British drugmaker said on Tuesday. The announcement marks the third time...
CCI clears SSI’s stake buy in Manipal Health Enterprises
Fair trade regulator Competition Commission of India (CCI) cleared Seventy Second Investment Company’s proposed stake acquisition in Manipal Health Enterprises. The deal has been approved under the green channel...
Apax initiates sale of Healthium Medtech
The British Private equity firm Apax Partners has started the process to sell Healthium Medtech, the largest homegrown surgical sutures manufacturer, said multiple people aware of the development. The proposed sale is...
Medical device maker Boston Scientific to buy Axonics for $3.7 billion
Medical device maker Boston Scientific said it had agreed to buy Axonics Inc for $3.7 billion, gaining access to devices used to improve bladder function. The deal marks Boston Scientific’s entry into sacral...
Quadria in talks to buy into dialysis chain NephroPlus
Quadria Capital, the Asia healthcare-focused private equity fund, is in advanced talks to acquire a significant minority stake in India’s largest dialysis chain NephroPlus, valuing the latter at ₹2,000 crore ($250...
Elevance’s deal to buy Paragon Healthcare valued at over $1 billion – Axios
Elevance Health will buy private firm Paragon Healthcare for more than $1 billion, according to three people familiar with the matter, Axios reported. The health insurer had said earlier on Thursday it would acquire...
ChrysCapital eyes stake in Delhi’s Centre for Sight eye hospital
Private equity (PE) fund ChrysCapital is in final discussions to acquire a significant minority stake in New Delhi’s Centre For Sight, valuing the eye hospitals chain at Rs 1,600 crore, said people aware of the...
Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
Bristol Myers Squibb said it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business, marking the second multi-billion dollar deal struck by the drugmaker in less than a week. Bristol Myers had...
General Atlantic set to acquire Amar Ujala’s hospital chain Cygnus Healthcare
The global private equity major General Atlantic is set to acquire about 70% stake in Ujala Cygnus Healthcare Services, the Delhi-based multi-specialty hospital chain owned by media group Amar Ujala, said multiple...
